MetaADEDB 2.0 @ LMMD
Trientine
(WYHIICXRPHEJKI-UHFFFAOYSA-N)
Structure
SMILES
NCCNCCNCCN.Cl.Cl
Molecular Formula:
C6H20Cl2N4
Molecular Weight:
219.156
Log P:
1.8694
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
6
TPSA:
76.1
CAS Number(s):
38260-01-4
Synonym(s)
1.
Trientine
2.
Triethylenetetramine
3.
Syprine
4.
Trien
5.
Trientine Dihydrochloride
6.
Trientine Hydrochloride
External Link(s)
MeSHD014266
PubChem Compound71433
ChEBI9706
CHEMBLCHEMBL3989777
KEGGdr:D00736
Therapeutic Target DatabaseD09VOK
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug dose omissionFAERS: 19US FAERS
2No adverse eventFAERS: 8US FAERS
3Product storage errorFAERS: 6US FAERS
4Drug ineffectiveFAERS: 4US FAERS
5Memory impairmentFAERS: 4US FAERS
6DyspepsiaFAERS: 3US FAERS
7FatigueFAERS: 3US FAERS
8Product distribution issueFAERS: 3US FAERS
9Weight decreasedFAERS: 3US FAERS
10Abdominal discomfortFAERS: 2US FAERS
11Blood copper increasedFAERS: 2US FAERS
12Drug administration errorFAERS: 2US FAERS
13DysarthriaFAERS: 2US FAERS
14Insurance issueFAERS: 2US FAERS
15MalaiseFAERS: 2US FAERS
16MyalgiaFAERS: 2US FAERS
17NauseaFAERS: 2US FAERS
18Product taste abnormalFAERS: 2US FAERS
19StressFAERS: 2US FAERS
20Therapy cessationFAERS: 2US FAERS
21Abdominal PainFAERS: 1US FAERS
22Abdominal tendernessFAERS: 1US FAERS
23ArthralgiaFAERS: 1US FAERS
24AstheniaFAERS: 1US FAERS
25Back PainFAERS: 1US FAERS
26Blood cholesterol increasedFAERS: 1US FAERS
27Blood triglycerides increasedFAERS: 1US FAERS
28BronchitisFAERS: 1US FAERS
29ChokingFAERS: 1US FAERS
30Complex partial seizuresFAERS: 1US FAERS
31ConstipationFAERS: 1US FAERS
32Diabetes MellitusFAERS: 1US FAERS
33DisabilityFAERS: 1US FAERS
34DizzinessFAERS: 1US FAERS
35DysgeusiaFAERS: 1US FAERS
36DysphoniaFAERS: 1US FAERS
37Expired product administeredFAERS: 1US FAERS
38Extra dose administeredFAERS: 1US FAERS
39FlushingFAERS: 1US FAERS
40HepatitisFAERS: 1US FAERS
41Incorrect product storageFAERS: 1US FAERS
42InfluenzaFAERS: 1US FAERS
43Limb discomfortFAERS: 1US FAERS
44Myasthenia GravisFAERS: 1US FAERS
45NasopharyngitisFAERS: 1US FAERS
46PainFAERS: 1US FAERS
47PneumoniaFAERS: 1US FAERS
48Product availability issueFAERS: 1US FAERS
49Product dose omissionFAERS: 1US FAERS
50SomnolenceFAERS: 1US FAERS
51SplenomegalyFAERS: 1US FAERS
52TremorFAERS: 1US FAERS
53White blood cell count decreasedFAERS: 1US FAERS
54Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.